Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms | 36 | 2024 | 6919 | 3.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 33 | 2022 | 5666 | 1.440 |
Why?
|
Coffee | 3 | 2022 | 593 | 1.410 |
Why?
|
Proto-Oncogene Proteins B-raf | 11 | 2024 | 2054 | 1.070 |
Why?
|
Tea | 2 | 2017 | 288 | 1.030 |
Why?
|
Alcohol Drinking | 6 | 2024 | 4027 | 0.920 |
Why?
|
Microsatellite Instability | 11 | 2024 | 716 | 0.920 |
Why?
|
CpG Islands | 9 | 2024 | 1190 | 0.910 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 6 | 2024 | 1089 | 0.880 |
Why?
|
Japan | 14 | 2023 | 1378 | 0.870 |
Why?
|
Hematologic Neoplasms | 7 | 2018 | 1895 | 0.830 |
Why?
|
Smoking | 6 | 2022 | 9055 | 0.800 |
Why?
|
Transplantation Conditioning | 15 | 2019 | 1591 | 0.750 |
Why?
|
Transplantation, Homologous | 20 | 2022 | 4822 | 0.730 |
Why?
|
Leukemia, Myeloid, Acute | 7 | 2022 | 3610 | 0.720 |
Why?
|
Myelodysplastic Syndromes | 4 | 2018 | 1393 | 0.660 |
Why?
|
Graft vs Host Disease | 13 | 2019 | 3025 | 0.660 |
Why?
|
Tumor Microenvironment | 8 | 2024 | 3875 | 0.620 |
Why?
|
Biological Specimen Banks | 1 | 2022 | 780 | 0.550 |
Why?
|
Fasciitis, Necrotizing | 2 | 2014 | 79 | 0.540 |
Why?
|
Neutropenia | 5 | 2017 | 885 | 0.540 |
Why?
|
Immunoglobulin kappa-Chains | 2 | 2013 | 170 | 0.520 |
Why?
|
Leukemia | 4 | 2019 | 1518 | 0.510 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2024 | 15920 | 0.500 |
Why?
|
Gram-Positive Bacterial Infections | 3 | 2015 | 342 | 0.500 |
Why?
|
Bone Marrow Transplantation | 3 | 2018 | 2692 | 0.470 |
Why?
|
Haemophilus influenzae type b | 1 | 2014 | 16 | 0.470 |
Why?
|
Bacillus cereus | 1 | 2014 | 36 | 0.460 |
Why?
|
Haemophilus Infections | 1 | 2014 | 94 | 0.450 |
Why?
|
Capnocytophaga | 1 | 2013 | 26 | 0.450 |
Why?
|
Bence Jones Protein | 1 | 2013 | 18 | 0.450 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2018 | 517 | 0.440 |
Why?
|
Fanconi Syndrome | 1 | 2013 | 34 | 0.430 |
Why?
|
Brain Abscess | 1 | 2014 | 120 | 0.430 |
Why?
|
Bacteremia | 6 | 2017 | 978 | 0.420 |
Why?
|
DNA Methylation | 9 | 2024 | 4384 | 0.420 |
Why?
|
Cephalosporins | 1 | 2014 | 198 | 0.420 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2913 | 0.410 |
Why?
|
Bacteroides fragilis | 2 | 2024 | 250 | 0.410 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 7 | 2024 | 1746 | 0.400 |
Why?
|
Gram-Negative Bacterial Infections | 2 | 2015 | 237 | 0.400 |
Why?
|
Multiple Myeloma | 3 | 2019 | 5145 | 0.380 |
Why?
|
Antilymphocyte Serum | 4 | 2019 | 491 | 0.380 |
Why?
|
Middle Aged | 65 | 2024 | 220858 | 0.370 |
Why?
|
Colonic Neoplasms | 1 | 2023 | 2527 | 0.360 |
Why?
|
Humans | 111 | 2024 | 761222 | 0.350 |
Why?
|
Neoplasms | 6 | 2024 | 22142 | 0.340 |
Why?
|
Prospective Studies | 23 | 2024 | 54437 | 0.340 |
Why?
|
Body Mass Index | 5 | 2024 | 12952 | 0.340 |
Why?
|
HLA Antigens | 4 | 2019 | 1331 | 0.320 |
Why?
|
Lymphoma | 2 | 2017 | 1898 | 0.320 |
Why?
|
Mumps | 2 | 2023 | 71 | 0.320 |
Why?
|
Helicobacter Infections | 3 | 2022 | 392 | 0.310 |
Why?
|
Female | 74 | 2024 | 392552 | 0.310 |
Why?
|
Incidence | 19 | 2024 | 21366 | 0.300 |
Why?
|
Adult | 56 | 2024 | 221120 | 0.300 |
Why?
|
Mutation | 15 | 2024 | 30004 | 0.290 |
Why?
|
Risk Factors | 28 | 2024 | 74241 | 0.290 |
Why?
|
Aged | 46 | 2024 | 169292 | 0.290 |
Why?
|
Male | 68 | 2024 | 360703 | 0.290 |
Why?
|
Waldenstrom Macroglobulinemia | 2 | 2014 | 1074 | 0.290 |
Why?
|
Spleen | 1 | 2013 | 2290 | 0.280 |
Why?
|
Lung Diseases, Fungal | 2 | 2019 | 125 | 0.280 |
Why?
|
Acyclovir | 3 | 2017 | 267 | 0.270 |
Why?
|
Aspergillosis | 3 | 2019 | 242 | 0.270 |
Why?
|
Polymorphism, Genetic | 1 | 2017 | 4243 | 0.270 |
Why?
|
Neoplasm Staging | 2 | 2020 | 11119 | 0.260 |
Why?
|
Anemia | 1 | 2015 | 1504 | 0.250 |
Why?
|
Follow-Up Studies | 14 | 2024 | 39127 | 0.250 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2016 | 11733 | 0.250 |
Why?
|
Genotype | 4 | 2024 | 12985 | 0.250 |
Why?
|
Prognosis | 14 | 2024 | 29688 | 0.250 |
Why?
|
Human T-lymphotropic virus 1 | 2 | 2017 | 142 | 0.250 |
Why?
|
Lung Diseases | 1 | 2015 | 1910 | 0.250 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2022 | 1549 | 0.250 |
Why?
|
Rectal Neoplasms | 1 | 2014 | 1156 | 0.250 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 2 | 2017 | 164 | 0.240 |
Why?
|
Brain Diseases | 1 | 2014 | 1545 | 0.240 |
Why?
|
Mumps Vaccine | 1 | 2023 | 16 | 0.220 |
Why?
|
Helicobacter pylori | 3 | 2022 | 382 | 0.220 |
Why?
|
Fusobacterium nucleatum | 2 | 2024 | 176 | 0.220 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 3 | 2024 | 899 | 0.220 |
Why?
|
Anemia, Aplastic | 2 | 2017 | 230 | 0.220 |
Why?
|
HLA-DR Antigens | 2 | 2021 | 606 | 0.210 |
Why?
|
Herpes Simplex | 2 | 2017 | 465 | 0.210 |
Why?
|
Phenotype | 8 | 2024 | 16575 | 0.200 |
Why?
|
T-Lymphocyte Subsets | 2 | 2021 | 1803 | 0.200 |
Why?
|
Ethanol | 2 | 2020 | 1322 | 0.200 |
Why?
|
Pathology, Molecular | 2 | 2022 | 329 | 0.200 |
Why?
|
Proportional Hazards Models | 6 | 2022 | 12474 | 0.200 |
Why?
|
Metalloendopeptidases | 1 | 2024 | 389 | 0.200 |
Why?
|
Herpes Zoster | 2 | 2015 | 253 | 0.190 |
Why?
|
Tissue Donors | 5 | 2019 | 2335 | 0.190 |
Why?
|
Sulfur-Reducing Bacteria | 1 | 2021 | 14 | 0.190 |
Why?
|
Keloid | 1 | 2022 | 55 | 0.190 |
Why?
|
DNA Glycosylases | 1 | 2022 | 124 | 0.190 |
Why?
|
DNA Mismatch Repair | 1 | 2024 | 428 | 0.190 |
Why?
|
Antifungal Agents | 2 | 2017 | 752 | 0.190 |
Why?
|
ROC Curve | 3 | 2020 | 3584 | 0.190 |
Why?
|
Cohort Studies | 10 | 2024 | 41496 | 0.190 |
Why?
|
Sulfur | 1 | 2021 | 160 | 0.180 |
Why?
|
Alkylating Agents | 1 | 2021 | 133 | 0.180 |
Why?
|
Young Adult | 22 | 2022 | 59222 | 0.180 |
Why?
|
Ovarian Neoplasms | 1 | 2018 | 4872 | 0.180 |
Why?
|
Registries | 1 | 2017 | 8246 | 0.180 |
Why?
|
Appendectomy | 1 | 2024 | 434 | 0.180 |
Why?
|
Fusobacterium Infections | 1 | 2021 | 53 | 0.180 |
Why?
|
Antibiotic Prophylaxis | 2 | 2017 | 637 | 0.180 |
Why?
|
Gene Products, tax | 2 | 2017 | 51 | 0.180 |
Why?
|
Cytomegalovirus | 2 | 2014 | 750 | 0.170 |
Why?
|
Myeloablative Agonists | 3 | 2016 | 209 | 0.170 |
Why?
|
Retrospective Studies | 27 | 2022 | 80675 | 0.170 |
Why?
|
Duodenal Ulcer | 1 | 2019 | 121 | 0.170 |
Why?
|
C-Reactive Protein | 3 | 2024 | 3821 | 0.170 |
Why?
|
Sepsis | 1 | 2013 | 2585 | 0.160 |
Why?
|
Granulocytes | 1 | 2021 | 550 | 0.160 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2017 | 1783 | 0.160 |
Why?
|
Adrenal Cortex Hormones | 3 | 2017 | 1878 | 0.160 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2023 | 380 | 0.160 |
Why?
|
Biopsy | 3 | 2015 | 6781 | 0.160 |
Why?
|
Diet | 4 | 2024 | 8048 | 0.150 |
Why?
|
Natural Killer T-Cells | 1 | 2021 | 322 | 0.150 |
Why?
|
Escherichia coli Infections | 1 | 2022 | 518 | 0.150 |
Why?
|
Stomach Diseases | 1 | 2019 | 134 | 0.150 |
Why?
|
Genes, ras | 1 | 2020 | 654 | 0.150 |
Why?
|
Asia | 1 | 2019 | 622 | 0.150 |
Why?
|
HTLV-I Infections | 2 | 2017 | 103 | 0.140 |
Why?
|
Folic Acid | 1 | 2024 | 1323 | 0.140 |
Why?
|
Neoplasm Proteins | 2 | 2019 | 3594 | 0.140 |
Why?
|
Partial Thromboplastin Time | 1 | 2018 | 204 | 0.140 |
Why?
|
Kaplan-Meier Estimate | 4 | 2020 | 6486 | 0.140 |
Why?
|
Fluconazole | 1 | 2017 | 156 | 0.140 |
Why?
|
Corynebacterium | 1 | 2016 | 48 | 0.140 |
Why?
|
Corynebacterium Infections | 1 | 2016 | 27 | 0.140 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2019 | 285 | 0.140 |
Why?
|
Anti-Bacterial Agents | 4 | 2017 | 7407 | 0.130 |
Why?
|
Cystatin C | 1 | 2017 | 270 | 0.130 |
Why?
|
Histocompatibility | 1 | 2017 | 319 | 0.130 |
Why?
|
Immunosuppressive Agents | 4 | 2017 | 4190 | 0.130 |
Why?
|
Horses | 1 | 2017 | 296 | 0.130 |
Why?
|
Adolescent | 20 | 2020 | 88300 | 0.130 |
Why?
|
Blood Platelets | 2 | 2017 | 2477 | 0.130 |
Why?
|
Postoperative Complications | 2 | 2015 | 15637 | 0.130 |
Why?
|
Tuberculosis, Meningeal | 1 | 2016 | 47 | 0.130 |
Why?
|
Bacterial Toxins | 2 | 2024 | 923 | 0.130 |
Why?
|
Bacterial Infections | 2 | 2014 | 1390 | 0.130 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1111 | 0.130 |
Why?
|
SEER Program | 1 | 2020 | 1453 | 0.120 |
Why?
|
Fatal Outcome | 3 | 2016 | 1838 | 0.120 |
Why?
|
Mannans | 1 | 2015 | 58 | 0.120 |
Why?
|
Fluoroquinolones | 1 | 2017 | 307 | 0.120 |
Why?
|
Metabolomics | 1 | 2024 | 1658 | 0.120 |
Why?
|
Antigens, Neoplasm | 2 | 2019 | 1985 | 0.120 |
Why?
|
Tumor Burden | 1 | 2020 | 1892 | 0.120 |
Why?
|
Premedication | 1 | 2015 | 246 | 0.120 |
Why?
|
Cyclophosphamide | 3 | 2016 | 2219 | 0.120 |
Why?
|
Rubella | 1 | 2014 | 55 | 0.110 |
Why?
|
Busulfan | 1 | 2015 | 258 | 0.110 |
Why?
|
Haplotypes | 2 | 2019 | 2715 | 0.110 |
Why?
|
Gram-Positive Bacteria | 1 | 2015 | 176 | 0.110 |
Why?
|
Thienamycins | 1 | 2013 | 29 | 0.110 |
Why?
|
Whole-Body Irradiation | 1 | 2014 | 432 | 0.110 |
Why?
|
Gastrointestinal Tract | 1 | 2020 | 834 | 0.110 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 226 | 0.110 |
Why?
|
Adenoma | 1 | 2024 | 2159 | 0.110 |
Why?
|
Life Expectancy | 1 | 2020 | 1242 | 0.110 |
Why?
|
Body Height | 1 | 2020 | 1566 | 0.110 |
Why?
|
Anti-Mullerian Hormone | 1 | 2016 | 407 | 0.110 |
Why?
|
Antiviral Agents | 2 | 2017 | 3048 | 0.110 |
Why?
|
Viral Matrix Proteins | 1 | 2014 | 193 | 0.110 |
Why?
|
Arsenicals | 1 | 2013 | 117 | 0.110 |
Why?
|
Thrombocytosis | 1 | 2013 | 88 | 0.110 |
Why?
|
Gram-Negative Bacteria | 1 | 2015 | 271 | 0.110 |
Why?
|
Antibodies, Viral | 2 | 2014 | 3149 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20588 | 0.110 |
Why?
|
Dexamethasone | 3 | 2016 | 1945 | 0.100 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 1613 | 0.100 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2013 | 83 | 0.100 |
Why?
|
Boronic Acids | 2 | 2014 | 915 | 0.100 |
Why?
|
Dog Diseases | 1 | 2013 | 141 | 0.100 |
Why?
|
Klebsiella Infections | 1 | 2014 | 144 | 0.100 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2013 | 286 | 0.100 |
Why?
|
Vidarabine | 1 | 2014 | 336 | 0.100 |
Why?
|
Calcitonin | 1 | 2014 | 329 | 0.100 |
Why?
|
Herpesvirus 3, Human | 1 | 2013 | 159 | 0.100 |
Why?
|
Chemoprevention | 1 | 2015 | 325 | 0.100 |
Why?
|
Pneumonia, Bacterial | 1 | 2015 | 316 | 0.100 |
Why?
|
T-Lymphocytes | 3 | 2022 | 10203 | 0.100 |
Why?
|
Treatment Outcome | 11 | 2019 | 64681 | 0.100 |
Why?
|
Medical Oncology | 1 | 2024 | 2320 | 0.100 |
Why?
|
Measles | 1 | 2014 | 181 | 0.100 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 686 | 0.100 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2020 | 955 | 0.100 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2013 | 350 | 0.100 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2013 | 410 | 0.100 |
Why?
|
Mouth Diseases | 1 | 2014 | 240 | 0.100 |
Why?
|
Fungi | 1 | 2015 | 337 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 5 | 2022 | 17897 | 0.100 |
Why?
|
Creatinine | 1 | 2017 | 1897 | 0.100 |
Why?
|
Trisomy | 1 | 2013 | 261 | 0.100 |
Why?
|
Peptides | 1 | 2024 | 4353 | 0.100 |
Why?
|
Sex Distribution | 1 | 2017 | 2277 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2021 | 2864 | 0.100 |
Why?
|
Oxides | 1 | 2013 | 401 | 0.100 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2013 | 249 | 0.100 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2015 | 382 | 0.100 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2013 | 430 | 0.100 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20982 | 0.100 |
Why?
|
Monocytes | 1 | 2021 | 2570 | 0.100 |
Why?
|
Virus Activation | 1 | 2013 | 319 | 0.100 |
Why?
|
Mycoses | 1 | 2015 | 386 | 0.100 |
Why?
|
Herpesvirus 1, Human | 1 | 2017 | 739 | 0.090 |
Why?
|
Logistic Models | 3 | 2024 | 13249 | 0.090 |
Why?
|
Erythropoiesis | 1 | 2015 | 683 | 0.090 |
Why?
|
Sex Factors | 3 | 2024 | 10553 | 0.090 |
Why?
|
Communicable Diseases | 2 | 2016 | 873 | 0.090 |
Why?
|
Cell Lineage | 1 | 2020 | 2549 | 0.090 |
Why?
|
Stem Cell Transplantation | 2 | 2022 | 1600 | 0.090 |
Why?
|
Pyrazines | 2 | 2014 | 1202 | 0.090 |
Why?
|
Hematologic Diseases | 1 | 2015 | 496 | 0.090 |
Why?
|
Heparin | 1 | 2018 | 1632 | 0.090 |
Why?
|
Rabbits | 1 | 2017 | 4750 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2020 | 2004 | 0.090 |
Why?
|
Vancomycin | 1 | 2013 | 503 | 0.090 |
Why?
|
Bone Marrow | 2 | 2018 | 2911 | 0.090 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2014 | 1351 | 0.090 |
Why?
|
Protein Precursors | 1 | 2014 | 1132 | 0.080 |
Why?
|
Clostridium Infections | 1 | 2016 | 557 | 0.080 |
Why?
|
Genome-Wide Association Study | 3 | 2024 | 12676 | 0.080 |
Why?
|
Body Size | 2 | 2024 | 463 | 0.080 |
Why?
|
Body Weight | 1 | 2020 | 4618 | 0.080 |
Why?
|
Feeding Behavior | 1 | 2021 | 3183 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2018 | 2159 | 0.080 |
Why?
|
Diagnostic Tests, Routine | 1 | 2015 | 788 | 0.080 |
Why?
|
Glomerular Filtration Rate | 1 | 2017 | 2182 | 0.080 |
Why?
|
Lymphocytes | 2 | 2015 | 2603 | 0.080 |
Why?
|
Saliva | 1 | 2013 | 828 | 0.080 |
Why?
|
Skin Diseases | 1 | 2017 | 1095 | 0.080 |
Why?
|
Blood Transfusion | 1 | 2015 | 1303 | 0.080 |
Why?
|
Dogs | 1 | 2013 | 3832 | 0.080 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2731 | 0.080 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2017 | 2549 | 0.080 |
Why?
|
Renal Insufficiency | 1 | 2014 | 808 | 0.070 |
Why?
|
GPI-Linked Proteins | 2 | 2019 | 470 | 0.070 |
Why?
|
Antineoplastic Agents | 3 | 2017 | 13632 | 0.070 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 3 | 2016 | 694 | 0.070 |
Why?
|
Shock, Septic | 1 | 2014 | 769 | 0.070 |
Why?
|
Translocation, Genetic | 1 | 2013 | 1391 | 0.070 |
Why?
|
Neutrophils | 2 | 2017 | 3763 | 0.070 |
Why?
|
Disease-Free Survival | 4 | 2023 | 6819 | 0.070 |
Why?
|
Bone and Bones | 1 | 2018 | 2568 | 0.070 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2014 | 1372 | 0.070 |
Why?
|
Immunoglobulin G | 2 | 2019 | 4537 | 0.070 |
Why?
|
Iron | 1 | 2015 | 1791 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 2 | 2021 | 2468 | 0.070 |
Why?
|
Macrophages | 1 | 2021 | 5755 | 0.070 |
Why?
|
Acute Disease | 4 | 2018 | 7226 | 0.070 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2016 | 1405 | 0.070 |
Why?
|
Erythrocytes | 1 | 2015 | 2413 | 0.060 |
Why?
|
Phosphoproteins | 1 | 2014 | 2444 | 0.060 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2014 | 1520 | 0.060 |
Why?
|
Age of Onset | 2 | 2024 | 3307 | 0.060 |
Why?
|
Odds Ratio | 1 | 2018 | 9652 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2020 | 2894 | 0.060 |
Why?
|
Survival Rate | 5 | 2018 | 12728 | 0.060 |
Why?
|
Germ-Line Mutation | 2 | 2024 | 1852 | 0.060 |
Why?
|
Child, Preschool | 4 | 2023 | 42225 | 0.060 |
Why?
|
Epidemiologic Factors | 1 | 2024 | 36 | 0.060 |
Why?
|
Inflammation | 1 | 2024 | 10759 | 0.060 |
Why?
|
Bacteroides Infections | 1 | 2024 | 89 | 0.060 |
Why?
|
Transplantation, Autologous | 2 | 2022 | 2112 | 0.060 |
Why?
|
Public Health | 1 | 2017 | 2672 | 0.060 |
Why?
|
Pneumonia | 1 | 2015 | 2142 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5842 | 0.050 |
Why?
|
Vincristine | 2 | 2016 | 1036 | 0.050 |
Why?
|
C-Peptide | 1 | 2024 | 442 | 0.050 |
Why?
|
Graft Survival | 3 | 2019 | 3843 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20118 | 0.050 |
Why?
|
Aged, 80 and over | 6 | 2024 | 58952 | 0.050 |
Why?
|
Kidney | 2 | 2017 | 7033 | 0.050 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2013 | 1640 | 0.050 |
Why?
|
Age Factors | 4 | 2020 | 18384 | 0.050 |
Why?
|
Infusions, Intravenous | 2 | 2018 | 2217 | 0.050 |
Why?
|
Fusobacterium | 1 | 2021 | 53 | 0.050 |
Why?
|
Social Sciences | 1 | 2021 | 40 | 0.050 |
Why?
|
Escherichia coli | 2 | 2024 | 4201 | 0.050 |
Why?
|
Bifidobacterium | 1 | 2021 | 96 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2024 | 22174 | 0.050 |
Why?
|
Diet, Vegetarian | 1 | 2022 | 180 | 0.040 |
Why?
|
Prednisone | 2 | 2016 | 1565 | 0.040 |
Why?
|
Hematoxylin | 1 | 2020 | 60 | 0.040 |
Why?
|
Risk Assessment | 2 | 2024 | 24022 | 0.040 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2020 | 69 | 0.040 |
Why?
|
Waist Circumference | 1 | 2024 | 933 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2018 | 9278 | 0.040 |
Why?
|
Disease Progression | 2 | 2016 | 13511 | 0.040 |
Why?
|
Acetaldehyde | 1 | 2020 | 39 | 0.040 |
Why?
|
Germ Cells | 1 | 2024 | 632 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 26072 | 0.040 |
Why?
|
Immunocompromised Host | 2 | 2017 | 858 | 0.040 |
Why?
|
Cytarabine | 1 | 2022 | 697 | 0.040 |
Why?
|
Lung | 2 | 2015 | 9979 | 0.040 |
Why?
|
Anthracyclines | 1 | 2022 | 285 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2021 | 470 | 0.040 |
Why?
|
Methotrexate | 2 | 2016 | 1718 | 0.040 |
Why?
|
Immunologic Memory | 2 | 2017 | 1361 | 0.040 |
Why?
|
Life Style | 2 | 2020 | 3907 | 0.040 |
Why?
|
Infant | 2 | 2020 | 36170 | 0.040 |
Why?
|
Canada | 1 | 2024 | 2125 | 0.040 |
Why?
|
Doxorubicin | 2 | 2016 | 2224 | 0.040 |
Why?
|
Mucormycosis | 1 | 2019 | 102 | 0.040 |
Why?
|
Adiponectin | 1 | 2024 | 1107 | 0.040 |
Why?
|
Electroencephalography | 1 | 2014 | 6242 | 0.040 |
Why?
|
Mendelian Randomization Analysis | 1 | 2024 | 1010 | 0.040 |
Why?
|
Immunotherapy | 1 | 2014 | 4642 | 0.040 |
Why?
|
Antigens, CD7 | 1 | 2017 | 29 | 0.040 |
Why?
|
Siblings | 1 | 2022 | 824 | 0.040 |
Why?
|
Feces | 1 | 2024 | 1490 | 0.040 |
Why?
|
Macrophage Activation | 1 | 2020 | 552 | 0.040 |
Why?
|
Metabolome | 1 | 2024 | 989 | 0.040 |
Why?
|
Histocompatibility Testing | 1 | 2018 | 716 | 0.030 |
Why?
|
Child | 3 | 2023 | 80154 | 0.030 |
Why?
|
Remission Induction | 1 | 2022 | 2392 | 0.030 |
Why?
|
United States | 5 | 2021 | 72341 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2020 | 1080 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2024 | 2113 | 0.030 |
Why?
|
Ganciclovir | 1 | 2016 | 253 | 0.030 |
Why?
|
Aging | 1 | 2014 | 8702 | 0.030 |
Why?
|
Heterozygote | 1 | 2022 | 2778 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2024 | 1855 | 0.030 |
Why?
|
Immunoglobulin Gm Allotypes | 1 | 2014 | 2 | 0.030 |
Why?
|
Aspergillus | 1 | 2015 | 94 | 0.030 |
Why?
|
Echinocandins | 1 | 2015 | 53 | 0.030 |
Why?
|
Lipopeptides | 1 | 2015 | 70 | 0.030 |
Why?
|
Fungemia | 1 | 2015 | 57 | 0.030 |
Why?
|
Obesity | 3 | 2023 | 12940 | 0.030 |
Why?
|
Propensity Score | 1 | 2022 | 1916 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2019 | 1743 | 0.030 |
Why?
|
HLA-A2 Antigen | 1 | 2014 | 209 | 0.030 |
Why?
|
Lymphocyte Depletion | 1 | 2016 | 602 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2024 | 3210 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2017 | 850 | 0.030 |
Why?
|
Atrophy | 1 | 2019 | 1633 | 0.030 |
Why?
|
DNA Damage | 1 | 2024 | 2443 | 0.030 |
Why?
|
Asparaginase | 1 | 2015 | 239 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1791 | 0.030 |
Why?
|
Transplantation Chimera | 1 | 2016 | 594 | 0.030 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2014 | 71 | 0.030 |
Why?
|
Galactose | 1 | 2015 | 294 | 0.030 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2014 | 84 | 0.030 |
Why?
|
Drug Therapy, Combination | 2 | 2014 | 6304 | 0.030 |
Why?
|
Tongue | 1 | 2017 | 403 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2021 | 2635 | 0.030 |
Why?
|
Time Factors | 4 | 2017 | 39957 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2022 | 4107 | 0.030 |
Why?
|
Platelet Count | 1 | 2016 | 782 | 0.030 |
Why?
|
Genetic Markers | 1 | 2019 | 2599 | 0.030 |
Why?
|
Social Class | 1 | 2022 | 1993 | 0.030 |
Why?
|
Survival Analysis | 2 | 2016 | 10088 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2194 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2015 | 958 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3590 | 0.020 |
Why?
|
Klebsiella pneumoniae | 1 | 2014 | 249 | 0.020 |
Why?
|
Valine | 1 | 2013 | 408 | 0.020 |
Why?
|
Drug Resistance, Viral | 1 | 2017 | 862 | 0.020 |
Why?
|
Chronic Disease | 2 | 2018 | 9319 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2015 | 1597 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15308 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2024 | 3410 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2014 | 924 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2017 | 1603 | 0.020 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2014 | 323 | 0.020 |
Why?
|
Area Under Curve | 1 | 2015 | 1636 | 0.020 |
Why?
|
Adiposity | 1 | 2020 | 1879 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2014 | 989 | 0.020 |
Why?
|
Population Surveillance | 1 | 2021 | 2598 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2016 | 1936 | 0.020 |
Why?
|
Clone Cells | 1 | 2014 | 1668 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2014 | 800 | 0.020 |
Why?
|
Infertility, Female | 1 | 2016 | 761 | 0.020 |
Why?
|
Immunity, Humoral | 1 | 2014 | 598 | 0.020 |
Why?
|
Needs Assessment | 1 | 2016 | 1141 | 0.020 |
Why?
|
Immunization | 1 | 2014 | 1218 | 0.020 |
Why?
|
Genetic Loci | 1 | 2019 | 2623 | 0.020 |
Why?
|
Immunoglobulin M | 1 | 2014 | 1527 | 0.020 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 8002 | 0.020 |
Why?
|
Cryopreservation | 1 | 2014 | 728 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 12747 | 0.020 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2020 | 2517 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3803 | 0.020 |
Why?
|
Thalidomide | 1 | 2013 | 885 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11067 | 0.020 |
Why?
|
Kinetics | 1 | 2015 | 6312 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8457 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2013 | 2509 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8519 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2017 | 5250 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1812 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3198 | 0.020 |
Why?
|
Regression Analysis | 1 | 2015 | 6345 | 0.020 |
Why?
|
Recovery of Function | 1 | 2016 | 2981 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2017 | 13402 | 0.020 |
Why?
|
Animals | 2 | 2017 | 168089 | 0.020 |
Why?
|
Immune Tolerance | 1 | 2014 | 2307 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15721 | 0.020 |
Why?
|
Preoperative Care | 1 | 2014 | 2241 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2014 | 2756 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8531 | 0.010 |
Why?
|
Antigens, CD | 1 | 2014 | 4009 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9616 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2015 | 5493 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 18927 | 0.010 |
Why?
|
Protein Binding | 1 | 2014 | 9297 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2014 | 5103 | 0.010 |
Why?
|
Signal Transduction | 1 | 2024 | 23419 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26200 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 29893 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 10218 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11855 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15841 | 0.010 |
Why?
|